1. Home
  2. SAMG vs STTK Comparison

SAMG vs STTK Comparison

Compare SAMG & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Silvercrest Asset Management Group Inc.

SAMG

Silvercrest Asset Management Group Inc.

HOLD

Current Price

$15.38

Market Cap

126.6M

Sector

Finance

ML Signal

HOLD

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$4.70

Market Cap

119.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SAMG
STTK
Founded
2002
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
126.6M
119.0M
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
SAMG
STTK
Price
$15.38
$4.70
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
$4.00
AVG Volume (30 Days)
43.6K
626.6K
Earning Date
03-05-2026
11-06-2025
Dividend Yield
5.48%
N/A
EPS Growth
N/A
N/A
EPS
0.72
N/A
Revenue
$125,322,000.00
$1,000,000.00
Revenue This Year
$3.44
N/A
Revenue Next Year
$9.39
N/A
P/E Ratio
$21.32
N/A
Revenue Growth
4.23
N/A
52 Week Low
$13.23
$0.69
52 Week High
$19.04
$4.89

Technical Indicators

Market Signals
Indicator
SAMG
STTK
Relative Strength Index (RSI) 55.69 75.73
Support Level $15.26 $4.09
Resistance Level $16.16 $4.89
Average True Range (ATR) 0.38 0.34
MACD -0.03 0.07
Stochastic Oscillator 32.21 89.50

Price Performance

Historical Comparison
SAMG
STTK

About SAMG Silvercrest Asset Management Group Inc.

Silvercrest Asset Management Group Inc is a wealth management firm focused on providing financial advisory and related family office services to ultra-high net-worth individuals and institutional investors. It advises clients on traditional investment strategies focused on equities, fixed income and cash as well as non-traditional investment strategies including hedge funds, private equity funds, real estate and commodities. It also provides clients with family office services and related administrative services, which include financial planning, tax planning and preparation, partnership accounting and fund administration, and consolidated wealth reporting. The company derives revenues principally from assets under management.

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

Share on Social Networks: